智通财经APP讯，HOME CONTRO(01747)公布，于2025年9月12日，公司董事会议决推行其业务扩展方案及相应的品牌重塑工作。董事会宣布，该集团已启动其在医疗保健领域的战略性布局以把握市场机遇，且作为起步，已在香港成立一家全资附属公司(香港附属公司)，推出新品牌系列的产品及服务。
透过成立香港附属公司与推出新品牌，董事认为该等战略性举措将可让集团以家庭健康作为切入点，探索构建健康监测与管理的生态体系以及创新医疗运营业务中所蕴藏的机遇。集团计划依托其在居家场景的既有业务基础，结合新董事在医疗健康领域的专业能力，与相关机构及专家协作，逐步发展及完善其大健康业务版图。于 2025年上半年，该集团在医疗健康领域展现初步成果，医疗保健解决方案板块占其整体收入约19.7%。基于全球大健康产业的良好前景，展望未来，集团将把握机遇在医疗健康领域推进战略性布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.